Shamburg News · 8-K filed Nov 18, 2026, 5:05 PM EST
ClearPoint Neuro Amends At-the-Market Sales Agreement with Stifel to $150 Million
CLPT · ClearPoint Neuro, Inc.
- Material agreement
- Financing
- Materiality: medium
On November 18, 2026, ClearPoint Neuro, Inc. and Stifel, Nicolaus & Company, Incorporated amended their At-The-Market Equity Offering Sales Agreement to increase aggregate sales proceeds from up to $50,000,000 to up to $150,000,000, inclusive of prior sales. As of the report date, approximately $22.5 million of shares had been sold under the original agreement, and approximately $27.5 million remained available under the existing ATM prospectus supplement. The agent's commission is up to 3.0% of gross sales price.
Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001193125-26-467272.
Written from the filing by Shamburg Markets. Figures are as reported by the company.